CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY (Unaudited) - USD ($) $ in Thousands	Total		Common Stock [Member]	Capital Surplus [Member]	Retained Earnings [Member]	Accumulated Other Comprehensive Loss [Member]
Balance at Dec. 31, 2022	$ 133,416		$ 13,214	$ 105,344	$ 63,482	$ (48,624)
Exercise of stock options	18		3	15
Stock option expense	42			42
Restricted stock grant expense	111			111
Vested stock grants			21	(21)
Cash dividends declared	(1,762)				(1,762)
Impact of adoption of CECL	(1,890)				(1,890)
Net income	5,791				5,791
Other comprehensive income (loss)	5,771					5,771
Balance at Mar. 31, 2023	141,497		13,238	105,491	65,621	(42,853)
Balance at Dec. 31, 2022	133,416		13,214	105,344	63,482	(48,624)
Net income	16,095
Balance at Sep. 30, 2023	135,727		13,253	105,862	72,384	(55,772)
Balance at Mar. 31, 2023	141,497		13,238	105,491	65,621	(42,853)
Stock option expense	68			68
Restricted stock grant expense	120			120
Vested stock grants			12	(12)
Cash dividends declared	(1,770)				(1,770)
Net income	5,651				5,651
Other comprehensive income (loss)	(3,127)					(3,127)
Balance at Jun. 30, 2023	142,439		13,250	105,667	69,502	(45,980)
Stock option expense	18			18
Restricted stock grant expense	180			180
Vested stock grants			3	(3)
Cash dividends declared	(1,771)				(1,771)
Net income	4,653				4,653
Other comprehensive income (loss)	(9,792)					(9,792)
Balance at Sep. 30, 2023	135,727		13,253	105,862	72,384	(55,772)
Balance at Dec. 31, 2023	153,040	[1]	13,258	106,045	73,781	(40,044)
Stock option expense	24			24
Restricted stock grant expense	171			171
Vested stock grants			21	(21)
Shares repurchased	(26)		(2)	(24)
Cash dividends declared	(1,770)				(1,770)
Net income	3,646				3,646
Other comprehensive income (loss)	(2,508)					(2,508)
Balance at Mar. 31, 2024	152,577		13,277	106,195	75,657	(42,552)
Balance at Dec. 31, 2023	153,040	[1]	13,258	106,045	73,781	(40,044)
Net income	12,405
Balance at Sep. 30, 2024	165,909		13,257	106,166	80,789	(34,303)
Balance at Mar. 31, 2024	152,577		13,277	106,195	75,657	(42,552)
Stock option expense	35			35
Restricted stock grant expense	217			217
Vested stock grants			28	(28)
Shares repurchased	(533)		(49)	(484)
Cash dividends declared	(1,772)				(1,772)
Net income	4,159				4,159
Adjustment for Masonry capital distribution	(83)				(83)
Other comprehensive income (loss)	(436)					(436)
Balance at Jun. 30, 2024	154,164		13,256	105,935	77,961	(42,988)
Stock option expense	35			35
Restricted stock grant expense	197			197
Vested stock grants			1	(1)
Cash dividends declared	(1,772)				(1,772)
Net income	4,600				4,600
Other comprehensive income (loss)	8,685					8,685
Balance at Sep. 30, 2024	$ 165,909		$ 13,257	$ 106,166	$ 80,789	$ (34,303)

[1] * Derived from audited Consolidated Financial Statements